MedPath

Primary Hyperoxaluria Mutation Genotyping

Completed
Conditions
Primary Hyperoxaluria
Interventions
Genetic: Genetic Analysis
Registration Number
NCT00589225
Lead Sponsor
Mayo Clinic
Brief Summary

This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.

Detailed Description

During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
902
Inclusion Criteria
  • You have been diagnosed, or you are in the process of being diagnosed Primary Hyperoxaluria
  • You have a family member diagnosed with Primary Hyperoxaluria
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Genetic AnalysisGenetic Analysis
Primary Outcome Measures
NameTimeMethod
To determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath